Literature DB >> 26115370

Rasch-ionale for neurologists.

Els K Vanhoutte1, Mieke C E Hermans2, Catharina G Faber2, Kenneth C Gorson3, Ingemar S J Merkies2,4,5, Jean-L Thonnard6,7.   

Abstract

Outcome measures are considered the most important tools to monitor patients' outcome in both clinical and research settings. Measuring the clinical state of patients is a fundamental part of our daily clinical practice and research that sometimes is taken for granted. In peripheral neuropathies, there are many scales available, but most of these are at the ordinal level. This paper will systematically address the types of scales available (being nominal, ordinal, interval, or ratio data-based) in terms of their strengths and weaknesses. The differences between classical test theory-based and modern test method-based outcome measures will be addressed with emphasis on Rasch methodology. Various steps will be highlighted as part of the evaluation and construction of outcome measures using the Rasch method, with the aim to increase the knowledge and utility of this technique. We argue that Rasch-built outcome measures should be used for future studies in neuromuscular disorders and their method of construction could be easily extrapolated to other neurological illnesses.
© 2015 Peripheral Nerve Society.

Entities:  

Keywords:  Rasch; classical test theory; item response theory; measurement; outcome measure

Mesh:

Year:  2015        PMID: 26115370     DOI: 10.1111/jns.12122

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  6 in total

Review 1.  Saving time and effort: Best practice for adapting existing patient-reported outcome measures in hepatology.

Authors:  Laith Alrubaiy; Hayley A Hutchings; Sarah E Hughes; Thomas Dobbs
Journal:  World J Hepatol       Date:  2022-05-27

Review 2.  All metrics are equal, but some metrics are more equal than others: A systematic search and review on the use of the term 'metric'.

Authors:  Núria Duran Adroher; Birgit Prodinger; Carolina Saskia Fellinghauer; Alan Tennant
Journal:  PLoS One       Date:  2018-03-06       Impact factor: 3.240

3.  Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.

Authors:  Ingemar S J Merkies; John-Philip Lawo; Jonathan M Edelman; Jan L De Bleecker; Claudia Sommer; Wim Robberecht; Mika Saarela; Jerzy Kamienowski; Zbigniew Stelmasiak; Orell Mielke; Björn Tackenberg; Jean-Marc Léger
Journal:  J Peripher Nerv Syst       Date:  2017-06       Impact factor: 3.494

Review 4.  The minimum clinically important difference: which direction to take.

Authors:  T H P Draak; B T A de Greef; C G Faber; I S J Merkies
Journal:  Eur J Neurol       Date:  2019-03-25       Impact factor: 6.089

5.  Development of grading scales of pedal sensory loss using Mokken scale analysis on the Rotterdam Diabetic Foot Study Test Battery data.

Authors:  Willem D Rinkel; M Hosein Aziz; Johan W Van Neck; Manuel Castro Cabezas; L Andries van der Ark; J Henk Coert
Journal:  Muscle Nerve       Date:  2019-07-24       Impact factor: 3.217

6.  Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease.

Authors:  Akin Nihat; Tze How Mok; Hans Odd; Andrew Geoffrey Bourne Thompson; Diana Caine; Kirsty McNiven; Veronica O'Donnell; Selam Tesfamichael; Peter Rudge; John Collinge; Simon Mead
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-01-12       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.